Korea Health Industry Development Institute

• Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

  Collaborator, Recruiting, 1,000 people, 18 May 2025

• Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke

  Collaborator, Terminated, 338 people, 12 Nov 2020

• South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention

  Collaborator, Completed, 152 people, 10 Jun 2019

• NCT03510572

  Collaborator, Early phase 1, Completed, 20 people, 27 Apr 2018

Sources: clinicaltrials.gov

• Quantitative FP-CIT PET analysis of dopaminergic degeneration in isolated REM sleep behavior disorder and early Parkinson's disease

  28 Sept 2026

• A multi-label deep learning system for simultaneous detection of nine fundus conditions

  25 Sept 2026

• Inotodiol prevents age-related muscle wasting by restoring mitochondrial function through liver X receptor beta signaling

  RS-2024-00507256, 25 Sept 2026

• Beyond conventional immunosuppression: tailoring perioperative management protocols for clinical xenotransplantation

  RS-2023-KH135842, 22 Sept 2026

• Risk of Dementia After Cholecystectomy in Older Adults: A Nationwide Retrospective Study

  HI22C0520, RS-2023-00266002, RS-2023-00266398, 21 Sept 2026

• Alcohol consumption and incident osteoarthritis: A nationwide population-based longitudinal study

  RS-2025-25460287, 15 Sept 2026

• CKD risk with tegoprazan versus proton pump inhibitors

  4 Sept 2026

• Association between preoperative physical exercise and the risk of postoperative venous thromboembolism: nationwide population-based cohort study

  4 Sept 2026

• Metabolic sarcopenia in the era of incretin-based therapy: a narrative review of mitochondrial determinants of muscle quality and emerging therapeutic strategies

  2 Sept 2026

• Deep learning model for simultaneous vertebral level localization and fracture detection on DXA vertebral fracture assessment images

  1 Sept 2026

• The force-producing fraction: Muscle quality as a therapeutic target in sarcopenia and a design framework for trials that can test it

  RS-2024-00507256, RS-2023-KH127715, RS-2024-00437692, RS-2024-00439685, 1 Sept 2026

• SoUth Korean study to PrEvent cognitive impaiRment and protect BRAIN health via Behavioral, Optimized, Organized Movement therapy (SUPERBRAIN-BOOM) in Mild Cognitive Impairment: Protocol for a Multicenter, Randomized Controlled Feasibility Trial

  RS-2024-00337993, 1 Sept 2026

• Mitochondrial Proteostasis Links Diabetes and Sarcopenia: Cross-Scale Convergence from Experimental Models to Human Multi-Omics

  1 Sept 2026

• Pre-Pregnancy Physical Activity Lowers Risk of Diet-Controlled but Not Insulin-Treated Gestational Diabetes Mellitus: A Korean Prospective Cohort Study

  RS-2022-KH129953, 31 Aug 2026

• Development and Clinical Application of Digital Biomarkers for Sarcopenia

  31 Aug 2026

• Induced pluripotent stem cells from discovery to translation

  RS-2025-02214578, 27 Aug 2026

• Socioeconomic Status Modifies the 20-Year Association Between Metabolic Syndrome and Incident Coronary Artery Disease: A Nationwide Cohort Study of Korean Adults

  RS-2025-19252970, 25 Aug 2026

• Red Cell Distribution Width as an Independent Prognostic Biomarker in MASLD

  RS-2025-02263271, RS-2025-02214757, 25 Aug 2026

• Genetic Assessment of Oesophageal Safety of GLP-1 and GIP Receptor Perturbation: A Drug-Target Mendelian Randomisation Study

  RS-2024-00437038, 24 Aug 2026

• Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs

  (RS-2025-24535069, 22 Aug 2026

Sources: api.crossref.org

• Risk Factors for Progression to Type 2 Diabetes Postgestational Diabetes —A Retrospective Cohort Study

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025